New Zealand markets close in 3 hours 8 minutes

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
902.40-19.90 (-2.16%)
At close: 04:59PM CEST
Full screen
Previous close922.30
Bid902.40 x 0
Ask903.30 x 0
Day's range902.40 - 916.00
52-week range525.10 - 1,033.20
Avg. volume2,501,992
Market cap4.018T
Beta (5Y monthly)0.15
PE ratio (TTM)45.30
EPS (TTM)19.92
Earnings date07 Aug 2024
Forward dividend & yield12.80 (1.39%)
Ex-dividend date22 Mar 2024
1y target est963.15
  • Zacks

    Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors

    In the most recent trading session, Novo Nordisk (NVO) closed at $133.28, indicating a +0.08% shift from the previous trading day.

  • Bloomberg

    Ozempic Maker Novo Tees Up Another Major Building Project

    (Bloomberg) -- Novo Nordisk A/S has secured land and planning permissions for what may be its next major factory site in Denmark as the 100-year-old company works to meet soaring demand for its weight loss drugs. Most Read from BloombergHarris Has Enough Delegates to Clinch Nomination for PresidentTrump Risks Getting Tables Turned on Him With New 2024 AdversaryWiz Rejects Google’s $23 Billion Offer, Seeks IPO InsteadA Six-Second Decision Shows How Harris Snapped Up DelegatesHarris Wins Soros Bac

  • Zacks

    ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment

    Two companies, Eli Lilly (LLY) and Novo Nordisk (NVO), have so far dominated the weight-loss drug market. Now, Roche recently announced encouraging Phase I trial data for its new obesity drug candidate.